Harrison, NYNCT01639508Now EnrollingIRB Ready

Non-Small Cell Lung Cancer Clinical Trial in Harrison, NY

Access cutting-edge non-small cell lung cancer treatment through this clinical trial at a research site in Harrison. Study-provided care at no cost to qualified participants.

Sponsored by Memorial Sloan Kettering Cancer Center

Quick Self-Assessment

See if you qualify for this Harrison location

Preparing your pre-screening questions...

Expert Care in Harrison

Access non-small cell lung cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-small cell lung cancer treatment provided free

Apply for This Harrison Location

Check if you qualify for this non-small cell lung cancer clinical trial in Harrison, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Harrison

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Harrison site if eligible
  4. 4Begin participation

About This Non-Small Cell Lung Cancer Study in Harrison

The purpose of this phase II study is to find out what effects cabozantinib (XL184) has, good and/or bad, in patients whose tumors one of the following gene changes RET, ROS1, or NTRK fusion, or increased MET or AXL activity. A phase II study looks at how effective a medication is at treating a specific type of cancer and collects information on the side effects of the study treatment. RET, ROS1, or NTRK fusion or increased MET or AXL activity gene leads to lung cancer cell growth. Cabozantini

Sponsor: Memorial Sloan Kettering Cancer Center

Who Can Participate

Inclusion Criteria

A subject must fully meet all of the following criteria to be eligible for the study: 1. The subject has a pathologic diagnosis of non-small cell lung carcinoma that is metastatic or unresectable. 2. Documented presence: 1. Group A: KIF5B/RET or related variant RET fusions. 2. Group B: any of the following aberrations ii. NTRK fusion iii. MET overexpression, amplification, or mutation iv. AXL overexpression, amplification, or mutation 3. Group C: ROS1 fusion 4. GROUP D: RET-fusion post-progression on selective RET inhibitor 3. The subject is ≥ 18 years old on the day of consent. 4. Measurable Disease by RECIST1.1 5. The subject has a Karnofsky performance status of \> 70%. 6. The subject has organ and marrow function and laboratory values as follows: 1. Absolute neutrophil count (ANC) ≥ 1500/mm3 without colony stimulating factor support 2. Platelets ≥ 100,000/mm3 Hemoglobin ≥ 9 g/dL 3. Bilirubin ≤ 1.5 × the upper limit of normal (ULN)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Harrison?

Yes, this clinical trial (NCT01639508) has an active research site in Harrison, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-Small Cell Lung Cancer Treatment Options in Harrison, NY

If you're searching for non-small cell lung cancer treatment options in Harrison, NY, this clinical trial (NCT01639508) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Harrison research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-small cell lung cancer clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Harrison, NY

See all lung cancer clinical trials recruiting in Harrison — not just this study.

Browse Lung Cancer Trials in Harrison

Ready to Join in Harrison?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Harrison, NY